icrf 193 has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LT; Hsieh, MH; Hsin, LW; Hung, TW; Li, TK; Lin, CC; Teng, SC; Tsai, CH | 1 |
| Cortés, F; Hajji, N; Mateos, S; Pastor, N | 1 |
| Chappell, MJ; Chin, SF; Errington, RJ; Khan, IA; Njoh, K; Smith, PJ | 1 |
| Furue, H | 1 |
1 review(s) available for icrf 193 and Neoplasms
| Article | Year |
|---|---|
[Topoisomerase inhibitors developing in Japan].
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzopyrans; Camptothecin; Diketopiperazines; Glycosides; Humans; Irinotecan; Neoplasms; Phenazines; Piperazines; Razoxane; Topotecan | 1993 |
3 other study(ies) available for icrf 193 and Neoplasms
| Article | Year |
|---|---|
Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Diketopiperazines; DNA Topoisomerases, Type II; Gene Deletion; Gene Knockdown Techniques; Humans; Mice; Neoplasms; Piperazines; Telomerase; Telomere Homeostasis; Telomere-Binding Proteins; Topoisomerase II Inhibitors | 2015 |
Modulation of radiation response by inhibiting topoisomerase II catalytic activity.
Topics: Aclarubicin; Animals; Cell Line; Cell Survival; Cricetinae; Diketopiperazines; DNA Damage; DNA, Kinetoplast; Enzyme Inhibitors; Humans; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Mutation; Neoplasms; Phosphoproteins; Piperazines; Radiation Tolerance; Topoisomerase II Inhibitors | 2006 |
Cell cycle checkpoint-guarded routes to catenation-induced chromosomal instability.
Topics: Aneuploidy; Cell Cycle; Cell Line; Chromosomal Instability; Diketopiperazines; DNA, Catenated; Genes, cdc; Humans; Models, Theoretical; Neoplasms; Piperazines; Polyploidy; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53 | 2008 |